139 related articles for article (PubMed ID: 25337589)
1. Fibroblast and Epidermal Growth Factors Utilize Different Signaling Pathways to Induce Anchorage-independent Cell Transformation in JB6 Cl41 Mouse Skin Epidermal Cells.
Lee CJ; Lee MH; Cho YY
J Cancer Prev; 2014 Sep; 19(3):199-208. PubMed ID: 25337589
[TBL] [Abstract][Full Text] [Related]
2. Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation.
Cho YY; Yao K; Kim HG; Kang BS; Zheng D; Bode AM; Dong Z
Cancer Res; 2007 Sep; 67(17):8104-12. PubMed ID: 17804722
[TBL] [Abstract][Full Text] [Related]
3. Molecular Targeting of ERKs/RSK2 Signaling Axis in Cancer Prevention.
Yoo SM; Cho SJ; Cho YY
J Cancer Prev; 2015 Sep; 20(3):165-71. PubMed ID: 26473154
[TBL] [Abstract][Full Text] [Related]
4. Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells.
Yoo SM; Lee CJ; Kang HC; Lee HS; Lee JY; Kim KD; Kim DJ; An HJ; Cho YY
Mol Carcinog; 2019 Jul; 58(7):1221-1233. PubMed ID: 30887599
[TBL] [Abstract][Full Text] [Related]
5. RSK2 as a key regulator in human skin cancer.
Cho YY; Lee MH; Lee CJ; Yao K; Lee HS; Bode AM; Dong Z
Carcinogenesis; 2012 Dec; 33(12):2529-37. PubMed ID: 22918890
[TBL] [Abstract][Full Text] [Related]
6. Fyn is a novel target of (-)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation.
He Z; Tang F; Ermakova S; Li M; Zhao Q; Cho YY; Ma WY; Choi HS; Bode AM; Yang CS; Dong Z
Mol Carcinog; 2008 Mar; 47(3):172-83. PubMed ID: 18095272
[TBL] [Abstract][Full Text] [Related]
7. Kaempferol targeting on the fibroblast growth factor receptor 3-ribosomal S6 kinase 2 signaling axis prevents the development of rheumatoid arthritis.
Lee CJ; Moon SJ; Jeong JH; Lee S; Lee MH; Yoo SM; Lee HS; Kang HC; Lee JY; Lee WS; Lee HJ; Kim EK; Jhun JY; Cho ML; Min JK; Cho YY
Cell Death Dis; 2018 Mar; 9(3):401. PubMed ID: 29540697
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).
Strutz F; Zeisberg M; Renziehausen A; Raschke B; Becker V; van Kooten C; Müller G
Kidney Int; 2001 Feb; 59(2):579-92. PubMed ID: 11168939
[TBL] [Abstract][Full Text] [Related]
9. Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.
Liu K; Cho YY; Yao K; Nadas J; Kim DJ; Cho EJ; Lee MH; Pugliese A; Zhang J; Bode AM; Dong Z; Dong Z
J Biol Chem; 2011 Jan; 286(3):2057-66. PubMed ID: 21098035
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin induction is required for tumor promoter-induced transformation of preneoplastic mouse cells.
Chang PL; Cao M; Hicks P
Carcinogenesis; 2003 Nov; 24(11):1749-58. PubMed ID: 12919959
[TBL] [Abstract][Full Text] [Related]
11. The role of glycogen synthase kinase 3beta in the transformation of epidermal cells.
Ma C; Wang J; Gao Y; Gao TW; Chen G; Bower KA; Odetallah M; Ding M; Ke Z; Luo J
Cancer Res; 2007 Aug; 67(16):7756-64. PubMed ID: 17699780
[TBL] [Abstract][Full Text] [Related]
12. RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity.
Yoo SM; Lee CJ; An HJ; Lee JY; Lee HS; Kang HC; Cho SJ; Kim SM; Park J; Kim DJ; Cho YY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018569
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
14. Aschantin targeting on the kinase domain of mammalian target of rapamycin suppresses epidermal growth factor-induced neoplastic cell transformation.
Lee CJ; Jang JH; Lee JY; Lee MH; Li Y; Ryu HW; Choi KI; Dong Z; Lee HS; Oh SR; Surh YJ; Cho YY
Carcinogenesis; 2015 Oct; 36(10):1223-34. PubMed ID: 26243309
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of fucoidan on activation of epidermal growth factor receptor and cell transformation in JB6 Cl41 cells.
Lee NY; Ermakova SP; Zvyagintseva TN; Kang KW; Dong Z; Choi HS
Food Chem Toxicol; 2008 May; 46(5):1793-800. PubMed ID: 18313192
[TBL] [Abstract][Full Text] [Related]
16. Effect of retinoic acid on the late-stage promotion of transformation in JB6 mouse epidermal cells in culture.
Gensler HL; Matrisian LM; Bowden GT
Cancer Res; 1985 May; 45(5):1922-5. PubMed ID: 3872711
[TBL] [Abstract][Full Text] [Related]
17. Novel wiring of the AKT-RSK2 signaling pathway plays an essential role in cancer cell proliferation via a G
Choi JS; Cho YY
Biochem Biophys Res Commun; 2023 Jan; 642():66-74. PubMed ID: 36566564
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of a new 1H-pyrrolo[3,2-c]pyridine derivative, KIST101029, on activator protein-1 activity and neoplastic cell transformation induced by insulin-like growth factor-1.
Yun HJ; Kim G; Khanal P; Kim K; Oh CH; Choi HK; Sohn H; Choi HS
Biol Pharm Bull; 2013; 36(9):1466-73. PubMed ID: 23748899
[TBL] [Abstract][Full Text] [Related]
19. Effects of MAP kinase inhibitors on epidermal growth factor-induced neoplastic transformation of human keratinocytes.
Mizuno H; Cho YY; Ma WY; Bode AM; Dong Z
Mol Carcinog; 2006 Jan; 45(1):1-9. PubMed ID: 16302268
[TBL] [Abstract][Full Text] [Related]
20. A Rising Cancer Prevention Target of RSK2 in Human Skin Cancer.
Arul N; Cho YY
Front Oncol; 2013; 3():201. PubMed ID: 23936765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
